Introduction: useful basic safety panel screening works by using purposeful assays, kinase/transporter profiling, and advanced visualization to detect off-focus on liabilities early, enhancing preclinical safety assessments. Just past week, a late-stage drug applicant unexpectedly showed adverse results that hadn’t appeared in before assays, ele